Adam P. Dicker, MD, PhD, FASTRO, FASCO

Contact Dr. Dicker

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6700
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium
  2. A newly developed OSL dosimeter based on beryllium oxide: BeO:Na,Dy,Er
  3. Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma
  4. Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
  5. A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer
  6. Innovations in research and clinical care using patient-generated health data
  7. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
  8. Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer
  9. Utilizing digital health to collect electronic patient-reported outcomes in prostate cancer: Single-arm pilot trial
  10. Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group
  11. A Pilot Study of Radiation Therapy in Combination with Pembrolizumab in Patients with Metastatic Renal Cell Cancer
  12. The role of lineage plasticity in prostate cancer therapy resistance
  13. Transcriptomic heterogeneity of androgen receptor activity defines a de novo low AR-active subclass in treatment Naïve primary prostate cancer
  14. Big Data From Small Devices: The Future of Smartphones in Oncology
  15. Clinical outcome assessments toolbox for radiopharmaceuticals
  16. Tumor-Derived Extracellular Vesicles Require β1 Integrins to Promote Anchorage-Independent Growth
  17. Telemedicine training in undergraduate medical education: Mixed-methods review
  18. Artificial intelligence in oncology: Current applications and future directions
  19. PARP-1 regulates DNA repair factor availability
  20. Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus